MicroRNAs (miRNAs) are endogenous small noncoding RNAs that decrease the expression levels of specific genes by translational repression, sequestration, and degradation of their mRNAs. Angiotensin II is an important modulator of adrenal zona glomerulosa cell physiology, including steroidogenesis and proliferation among many other physiological processes. Because each miRNA may regulate the expression levels of multiple genes, thereby resembling the transcription regulatory networks triggered by transcription factors, we hypothesize that specific miRNAs may be involved in angiotensin II-mediated adrenocortical cell physiology. The human adrenocortical cell line H295R is the only adrenal cell line available with a steroid secretion pattern and regulation similar to freshly isolated adrenocortical cells. We T HE MAMMALIAN ADRENAL cortex is composed of three distinct zones: the zona glomerulosa, the zona fasciculata, and the zona reticularis (1, 2). The cells in the zona glomerulosa, underlying the adrenal capsule, secrete mineralocorticoids, primarily aldosterone. Aldosterone is mainly under the control of angiotensin II (Ang II), the end product of the renin-angiotensin system (RAS), although many other molecules also regulate its secretion (3, 4). Aldosterone exerts its effect in not only epithelial target tissues, in which its main function is regulation of sodium, potassium, and water balance but also in nonepithelial tissues such as the brain and the heart. High circulating aldosterone levels, due to a dysregulation of normal physiological secretion, has serious deleterious effects in multiple systems. In experimental animal models, excess aldosterone causes hypertension and heart, brain, and kidney target organ damage (5-9). In humans, high circulating levels of aldosterone due to primary aldosteronism have been associated with hypertension and target organ injury in the heart and kidney (10, 11). In addition, aldosterone levels in the highest quartile of the normal range for this steroid in nonhypertensive patients has been reported to correlate with an increased risk to suffer an increase in blood pressure or develop hypertension (12, 13).
untranslated region (UTR) of the target mRNA. The miRISC complex will specifically down-regulate the expression of the target mRNA by multiple mechanisms including mainly translational repression and sequestration in P bodies but also deadenylation, decapping, and degradation (20 -23) .
Although at the beginning they were considered a curiosity in nematodes, miRNAs have been described in viruses, plants, and animals, with more than 474 miRNAs reported in humans. Although the regulation of miRNA expression, their targets, and their physiological actions are not well understood, it is clear that they play a crucial role in multiple physiological processes. More than a decade ago, it was reported that lin-4 plays a crucial role in the progression from the first to the second larval stage in Caenorhabditis elegans (24, 25) . Evidence of miRNA importance in development was reinforced when it was found that the miRNA let-7 is essential for late-larval to adult cell progression in the same nematode experimental model (26, 27) . Recently multiple groups have shown that miRNAs are also required for normal mammal physiology. Knockdown of specific miRNAs causes severe pathologies in the immune and cardiac systems (28 -31) . miRNA mode of action targeting multiple genes and the important effects observed in specific miRNA knockout experimental models suggest that miRNAs may trigger gene expression regulatory networks similarly to the well-known transcription factors (32) .
Due to the importance of miRNAs in the control of cell physiology in multiple experimental models and the lack of knowledge of the role of miRNAs in adrenal cell physiology, we studied whether Ang II, an important modulator of adrenal cell physiology, regulates the expression of specific miRNAs in human adrenocortical cells. We screened more than 200 miRNAs by microarray analysis and found that miRNA-21 was the only miRNA whose expression levels were up-regulated by Ang II treatment in H295R human adrenocortical cells. miRNA-21 is a highly conserved miRNA expressed from its own transcription unit (15, 33, 34) . miRNA-21 expression is increased in tumor tissues and has been described as an oncogenic miRNA exhibiting antiapoptotic activity in various carcinomas (35, 36) . miRNA-21 is expressed, regulated, and functional in cardiac tissue (37) (38) (39) . Cardiac expression of miRNA-21 has been reported to be increased in vivo in experimental models of cardiac hypertrophy and in vitro by Ang II and phenylephrine in neonatal rat cardiomyocytes (37, 38) . The physiological role of cardiac miRNA-21 is unclear because it has been reported to mediate and inhibit Ang II-and phenylephrine-mediated cardiomyocyte proliferation by different research groups (37, 38) .
The aim of the present study was to study the regulation of miRNA-21 expression and its physiological role in H295R human adrenocortical cells. We used the human adrenocortical cell line H295R, which is the only adrenal cell line that expresses all of the steroidogenic enzymes required for the synthesis of aldosterone from cholesterol, has a steroid secretion pattern and regulation similar to that of primary adrenal cells cultures, and has been proven to be an excellent model to study adrenal cell physiology (40, 41) . We report Ang II-mediated regulation of miRNA-21 in H295R cells, its biological activity, and role in the two main physiological effects of Ang II on adrenocortical cells, steroid secretion, and proliferation.
Materials and Methods Materials
Ang II was obtained from American Peptide Co. (Sunnyvale, CA). miRNA primer pairs (miRNA-21: catalog no. 30102; U6: catalog no. 30303; S5: catalog no. 30302), miRNA precursors (pre-miRs, pre-miRNA-21: catalog no. 17100 ID: PM10206; pre-miR-negative control no. 1: catalog no. 17110; pre-miR-negative control no. 2: catalog no. 17111), and miRNA inhibitors (anti-miR-21: catalog no. 17000 ID: AM10206; antimiR-negative control no. 1: catalog no. 17010) were obtained from Ambion (Austin, TX). Pre-miR-negative controls no. 1 and 2 and anti-miRnegative control are designed not to target any known gene sequence.
Plasmids
pMIR-REPORT-miRNA-21 and its control plasmid have been previously reported (42) . pSEAP2-control plasmid was obtained from CLON-TECH (Mountain View, CA). pCMV-miRNA-21 and its control has been previously reported (43) .
Cell culture
H295R human adrenocortical cells (44) were cultured in H295R complete media containing DMEM:F12 (1:1) supplemented with 2% Ultroser G (Biosepra, Villeneuve-la-Garenne, France), Insulin/Transferrin/Selenium-Plus (Discovery Labware, Bedford, MA) and antibiotic/antimycotic mixture (Invitrogen, Carlsbad, CA) as we previously described (45) , until subconfluent in 6-well plates. Media were replaced with 3 ml fresh media containing various agents and cultured for periods indicated in each experimental protocol.
miRNA extraction and real-time RT-PCR
miRNA was extracted with the mirVana miRNA isolation kit (Ambion) and miRNA-21 quantification was performed using the mirVana quantitative RT-PCR miRNA detection kit (Ambion) following the manufacturer's suggested protocols. Total RNA (25 ng) was reversed transcribed using gene-specific primers. For real-time PCR, gene-specific reverse transcribed products were amplified with SuperTaq DNA polymerase (Ambion) and gene-specific primers. Reaction conditions were 3 min at 95 C followed by 50 cycles of 15 sec at 95 C and 30 sec at 60 C. Real-time data were obtained during the extension phase and threshold cycle values were obtained at the log phase of each gene amplification. PCR product quantification was performed by the relative quantification method (46) and standardized against U6 or S5 RNA. Efficiency for each primer pair was assessed by using serial dilutions of reverse transcriptase product. Results are expressed as arbitrary units and normalized against U6 or S5 RNA expression. The specificity of the PCR products was confirmed by melting temperature determination of the PCR product and high-resolution electrophoretic analysis in 4% NuSieve 3:1 agarose gels (Cambrex, Rockland, ME) of PCR products. Gene-specific primers were obtained from Ambion.
Reporter assays
H295R cells were plated in 24-well plates with media without antibiotic/antimycotics and grown until 90 -95% confluent. H295R cells were transfected with 3 g plasmid DNA/well (2.5 g reporter plasmid plus 0.5 g pSEAP2-control plasmid) and 2 l/well Lipofectamine 2000 (Invitrogen) following the manufacturer's suggested protocols. Cells were cultured overnight, media replaced with 1 ml/well fresh media with or without Ang II (100 nm), and cultured for an additional 24 h. Media were collected to measure secreted alkaline phosphatase using the Great EscAPe SEAP chemiluminescence kit (CLONTECH). Cells were lysed with Glo Lysis buffer (Promega, Madison, WI) and luciferase activity quantified with Bright-Glo luciferase assay kit (Promega).
Steroid secretion
H295R cells were transfected using Nucleofector technology (Amaxa Biosystems, Gaithersburg, MD). Three million log phase cells were resuspended in 100 l Nucleofector solution R, mixed with 100 picomoles miRNA precursors, miRNAs inhibitors or 3 g plasmid DNA, and electroporated using the proprietary program T-20. Cells were allowed to recover for 15 min in RPMI 1640 media at 37 C. Cells were plated in 24-well plates with 1 ml H295R complete media per well and allowed to recover for 16 h. Cell culture media was removed and replaced with media with or without Ang II (10 nm) and cells cultured for an additional 24 h. At the end of the incubation period, cell culture supernatants were saved for aldosterone and cortisol determination by ELISA as previously reported (47, 48) . Cells were lysed with M-PER lysis buffer (Pierce, Rockford, IL) and protein concentration measured by the bicinchoninic acid method (Pierce) using BSA as standard.
Cell proliferation
H295R cells were transfected using Nucleofector technology (Amaxa Biosystems). Three million log phase cells were resuspended in 100 l Nucleofector Solution R, mixed with 100 pmol miRNA precursors, and electroporated using the proprietary program T-20. Cells were allowed to recover for 15 min in RPMI 1640 media at 37 C. Cells (10 4 cells/well) were plated in 96-well plates with 0.2 ml H295R complete media per well and allowed to recover for 16 h. Cell culture media were removed and replaced with media with or without Ang II (10 nm) and cells cultured for an additional 24 h. Cell proliferation was quantified using the CellTiter-Glo luminescent cell viability assay kit (Promega) following manufacturer suggested protocol.
Statistics
All results were expressed as mean Ϯ sem. Two groups were compared by t test and multiple groups were analyzed by one-way ANOVA followed by Tukey's post hoc comparisons or two-way ANOVA followed by Bonferroni comparisons. Time-response curves were tested by twoway ANOVA followed by Bonferroni comparisons. All experiments were performed at least twice in triplicates. Differences were considered statistically significant at P Ͻ 0.05. Statistical calculations were performed with GraphPad Prism package version 4.03 (GraphPad Software, Inc., San Diego, CA).
Results

miRNA-21 is up-regulated by Ang II in H295R cells
H295R human adrenocortical cells were incubated with 100 nm Ang II for periods of increasing duration up to 24 h, and miRNA-21 expression was quantified by real-time PCR (Fig. 1) . Ang II increased miRNA-21 expression in H295R cells continuously between 6 and 24 h after hormone treatment reaching a maximal 4.4-fold stimulation after 24 h of treatment. The small RNA U6 was used as the housekeeping control to normalize miRNA-21 expression. To confirm Ang II-mediated miRNA-21 expression, we used another small RNA S5 as housekeeping control obtaining similar results (data not shown). To test the effect of another aldosterone secretagogue on miRNA-21 expression, H295R cells were treated with a maximal stimulatory concentration of potassium (16 
miRNA-21 is biologically active in H295R cells
To test whether Ang II-mediated increase in miRNA-21 expression is indeed translated into an increase in biologically active miRNA-21 in adrenal cells, we performed reporter studies. We used a reporter plasmid that expresses, under the control of a constitutive promoter, a fusion mRNA that encodes for the luciferase reporter enzyme fused to miRNA-21 target sequences in its 3Ј UTR. miRNA-21 became bound to its target sequences in the fusion mRNA, decreasing the concentration of luciferase and consequently its activity. Control plasmids did not carry the miRNA-21 target sequences. Ang II time-dependently decreased luciferase activity indicating that Ang II-mediated miRNA-21 expression is translated into an increase of biologically active miRNA-21 (Fig. 2) . Nonstimulated cells transfected with the miRNA-21 reporter plasmid showed a reduction in luciferase activity due to the basal expression of miRNA-21 that did not change during the course of the experiment. precursors, allowed to recover, and then incubated in the presence or absence of a submaximal Ang II concentration (10 nm). Increased levels of miRNA-21 caused an almost 70% increase in aldosterone secretion under Ang II submaximal stimulatory conditions and did not cause any significant effect under basal conditions (Fig. 3A) . To test the specificity of the miRNA-21 effect on steroid secretion, we quantified cortisol secretion in the same cell culture media. Increased levels of miRNA-21 did not modify cortisol secretion by H295R cells under basal or Ang II-stimulatory conditions (Fig. 3B) .
miRNA-21 increases aldosterone secretion by H295R cells
To confirm that transfected synthetic miRNA-21 precursors translate into increased levels of biologically active miRNA-21, we performed cotransfection studies with miRNA-21 precursors and miRNA-21 reporter plasmids. Transfection of synthetic miRNA-21 precursors caused an almost 25% decrease in the activity of the miRNA-21 reporter plasmid indicating the success of the transfection conditions (Fig. 3C) .
To further confirm the effect of increased levels of miRNA-21 on aldosterone secretion we up-regulated miRNA-21 intracellular concentration using a plasmiddriven overexpression system under the control of a constitutive promoter. Plasmid-driven miRNA-21 overexpression caused a 62% increase in aldosterone secretion under Ang II submaximal stimulatory conditions by H295R cells (8.23 Ϯ 1.09 vs. 13.37 Ϯ 1.93 pg aldosterone per microgram protein per day, P Ͻ 0.05, n ϭ 3).
Because elevated intracellular levels of miRNA-21 consistently increased aldosterone secretion using several experimental approaches, we tested whether miRNA-21 inhibition would modulate basal or Ang II-mediated aldosterone secretion. H295R cells were transfected with miRNA-21 inhibitors (or their controls), allowed to recover, and then incubated in the presence or absence of a submaximal Ang II concentration (10 nm) . Surprisingly, miRNA-21 inhibition did not modify either basal or Ang II-stimulated aldosterone or cortisol secretion.
miRNA-21 increases adrenal cell proliferation by H295R cells
To study the role of miRNA-21 up-regulation in adrenal cell proliferation, we transfected H295R cells with miRNA-21 precursors and studied cell proliferation under basal and Ang II-stimulated conditions. Increased levels of miRNA-21 precursors increased H295R cells proliferation 33 and 26% under basal and Ang II stimulatory conditions, respectively (Fig. 4) .
Discussion
The main finding of this report is that the endogenous miRNA miRNA-21 is up-regulated by the aldosterone secretagogue Ang II in H295R human adrenocortical cells and its up-regulation caused a specific increase in aldosterone secretion and cell proliferation. To the best of our knowledge, this is the first report describing a physiological role of an endogenous miRNA in adrenocortical cells.
miRNAs are not new to mammalian genetics, although it has only been in recent years that they are beginning to be considered not as a curiosity but as a completely new layer in gene expression regulation. miRNAs act by several pathways, including translational repression and mRNA sequestration and degradation, but all ultimately result in the decrease of the protein levels of specific genes. Nevertheless, miRNAs have also been recently reported to be able to bind to the 3Ј UTR of specific mRNAs up-regulating its translation (49) . The limited current knowledge regarding the specific targets for each miRNA or the availability of reliable bioinformatic tools to predict them in silico does not diminish their fundamental role, as has been reported in multiple living organisms (50 -52) including mammals (28 -31) .
In this report, we show that Ang II, the end product of the RAS, up-regulates miRNA-21 expression in human adrenocortical cells. The RAS is an important modulator of adrenal zona glomerulosa cell physiology (3, 4) . We also showed that Ang II-mediated miRNA-21 expression is translated into an increase in biologically active miRNA-21 expression capable of decreasing the expression/activity of a fusion mRNA reporter gene. miRNA-21 has been shown to be regulated not only in tumors but also more recently under physiological conditions in the cardiac tissue. Cardiac expression of miRNA-21 has been reported to be increased in in vivo experimental models of cardiac hypertrophy (37) (38) (39) . In vitro, both Ang II and phenylephrine up-regulate miRNA-21 expression in neonatal rat cardiomyocytes (37, 38) . This finding may suggest that Ang II is a key modulator of miRNA-21 expression as has been reported in neonatal rat cardiomyocytes and as we have observed in human adrenocortical cells.
Surprisingly, potassium, another aldosterone secretagogue, did not modify miRNA-21 expression levels in H295R cells, suggesting that miRNA-21 is a specific target of Ang II action in human adrenocortical cells. We did not quantify the expression levels of other miRNAs under potassium treatment in H295R cells, raising the possibility that potassium may regulate the expression levels of other miRNAs, which may have similar or different mRNA targets.
TarBase, a database of experimentally validated miRNA targets, lists 102 translational repressed validated miRNA targets as well as 359 down-regulated or cleaved miRNA targets for the human (53) . Three mRNA targets have been validated for miRNA-21 using mRNA fusion reporter genes with the 3Ј UTR regions of tropomyosin 1, phosphatase and tensin homolog deleted on chromosome 10, and programmed cell death 4 mRNAs (54 -56). Unfortunately, tropomyosin 1, phosphatase and tensin homolog deleted on chromosome 10, or programmed cell death 4 has not been studied in adrenal cortex cells in relation to steroid secretion or proliferation. Further studies are needed to address whether either of these validated miRNA-21 targets are also targeted by miRNA-21 in adrenocortical cells or whether any of them is responsible for the physiological effects observed with miRNA-21 up-regulation. We observed that miRNA-21 overexpression increased aldosterone secretion and proliferation in H295R cells. These results suggest that miRNA-21 may be down-regulating the expression of genes that are inhibitors of aldosterone secretion and proliferation. These inhibitory genes could be the same or different for the two physiological processes under study, aldosterone secretion and proliferation.
In contrast to our expectations, miRNA-21 inhibition did not modify aldosterone or cortisol secretion by H295R cells under either basal or Ang II-stimulatory conditions. Potential explanations for these apparently contradictory results are that miRNA-21 inhibition was not complete, and low levels of miRNA-21 are enough to sustain Ang IImediated aldosterone secretion or the existence of compensatory intracellular mechanisms, which deal with decreased levels of bioactive miRNA-21, among many other explanations. Similar discordant results from experiments with miRNA-21 overexpression and down-regulation have been reported in other cell systems (38, 39) .
Excess circulating aldosterone levels are associated with hypertension in experimental animal models and humans. Hypertension is a well-established determinant of cardiovascular disease and a major cause of disability and death (57) . The prevalence of hypertension in the adult population in the United States is approximately 29% (58) . Hypertension is a worldwide health problem with an estimated 1 billion hypertensive adults worldwide, two thirds of them in economically developing countries (59) . If the current trend persists, it is estimated that there would be a 60% increase in the number of hypertensive adults by 2025. Multiple epidemiological studies indicate that primary aldosteronism is the most common cause of secondary hypertension, accounting for approximately 10% of hypertensive patients (60 -62) . Current estimates indicate that there are 8.5 million people in the United States with primary aldosteronism.
Transcription factors have been implicated in multiple diseases in the last decades. miRNAs with similar potential of regulating multiple gene networks may be involved as the transcription factors in the modulation of the intracellular expression network whose dysregulation may lead to disease. We have shown that miRNA-21 is regulated by Ang II in human adrenal cells and that it is involved in the regulation of aldosterone secretion. Multiple questions about miRNA-21 remain open, including whether miRNA-21 endogenous levels are regulated by other aldosterone secretagogues such as endothelin-1 or ACTH, miRNA-21 is similarly regulated by Ang II in adrenocortical cells from other species, miRNA-21 levels are regulated in vivo by Ang II and adrenocortical cell physiological stimulators such as low-salt diet or elevated potassium, and the physiological targets of miRNA-21 and how these interact to specifically up-regulate aldosterone secretion, among many other questions. We hope this report will stimulate further research in these areas. The present report allows the speculation that miRNAs and specifically miRNA-21 may be involved in excess aldosterone secretion in patients with primary aldosteronism.
